An observational study identified plasma proteomic signatures linked to Parkinson’s disease cognitive vulnerability, with lysosomal proteins emerging as replicating signals across cohorts. Using longitudinal discovery data from the Parkinson’s Progression Markers Initiative and independent validation via the Parkinson’s Disease Biomarkers Program (Olink and SomaScan platforms), researchers reported 284 discriminating proteins and five cognition-linked co-expression modules. Across both cohorts, elevated Cathepsin D, Cathepsin Z, and Cystatin C associated with cognitive and motor impairment, supporting a lysosome-focused biomarker direction for forecasting decline risk.
Get the Daily Brief